Clinical Trials Logo

Clinical Trial Summary

Vasoactive intestinal peptide (VIP) is a peptide of 28 amino acid residues that belongs to the glucagon/secretin superfamily of peptides. It is produced in different regions of the nervous system, including the brain, trigeminovascular system and several autonomic nerves. Once released from neurons, it acts on vasoactive intestinal peptide receptor 1 (VPAC1), vasoactive intestinal peptide receptor 2 (VPAC2) and pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1), by mediating smooth muscle relaxation, vasodilation and water secretion. Along with other neuropeptides, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP), it is released from the trigeminal afferents and exerts a strong vasodilating activity on the cranial vasculature, sharing the activation of adenylate cyclase. Especially, it shares 70% structure with PACAP and acts on the same receptors. But, unlike it, VIP cannot induce a long-lasting vasodilation and has a modest capability to induce migraine attacks. Whether a long-lasting infusion of VIP may induce a prolonged vasodilation in the cerebral vessels and migraine, as a twenty-minute infusion of PACAP, is unknown.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03989817
Study type Interventional
Source Danish Headache Center
Contact
Status Completed
Phase N/A
Start date June 14, 2019
Completion date June 30, 2020

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03632928 - Day to Day Variation of Pressure Pain Threshold and Muscle Hardness
Completed NCT00246350 - Spinal Manipulation for Treatment of Chronic Headaches Phase 2
Completed NCT05404113 - Sustained Natural Apophyseal Glide and Deep Friction Massage in Patients With Cervicogenic Headache N/A
Recruiting NCT03416114 - RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres N/A
Enrolling by invitation NCT04976985 - Osteopathic Manipulative Treatment and Migraine Headaches N/A
Completed NCT05153876 - An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
Recruiting NCT06041997 - Smartphone Use Restriction as Treatment of Primary Headache N/A
Active, not recruiting NCT04936321 - Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial N/A
Completed NCT04220580 - Multiomics After Cold Pressor Test of People Who Are Unable to Have Headache N/A
Completed NCT03385174 - Carbon Monoxide Headache Triggering Properties as Well as Effects on the Brain's Vessels and Blood Flow N/A
Completed NCT03137147 - Intervention for Sleep and Pain in Youth N/A
Completed NCT02910921 - Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit
Recruiting NCT05619354 - Validity and Reliability of the Dutch HDI
Recruiting NCT06206772 - Resting State Functional Connectivity in Cluster Headache
Terminated NCT02624661 - Glycerol Block of the Trigeminal Ganglion in Trigeminal Neuralgia Using a New Neuronavigation-based Surgical Technique Phase 1/Phase 2
Completed NCT02662972 - Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues. Phase 1/Phase 2
Completed NCT05381012 - Fibromyalgia Syndrome on Patients With Chronic Migraine N/A
Completed NCT04891848 - Assessment of Inflammation in Primary Headaches
Recruiting NCT04715685 - Mind Body Balance for Pediatric Migraine N/A
Completed NCT00457496 - Effectiveness of a Cognitive and Physical Intervention to Reduce Head and Muscle Pain in Working Communities Phase 3